Cargando…
CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer
BACKGROUND: Globally, lung cancer causes the most cancer death. While molecular therapy progress, including epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), has provided remarkable therapeutic effects, some patients remain resistant to these therapies and therefore new targ...
Autores principales: | Nagoya, Akihiro, Sada, Ryota, Kimura, Hirokazu, Yamamoto, Hideki, Morishita, Koichi, Miyoshi, Eiji, Morii, Eiichi, Shintani, Yasushi, Kikuchi, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087988/ https://www.ncbi.nlm.nih.gov/pubmed/37057110 http://dx.doi.org/10.21037/tlcr-22-571 |
Ejemplares similares
-
DKK1‐CKAP4 signal axis promotes hepatocellular carcinoma aggressiveness
por: Iguchi, Kosuke, et al.
Publicado: (2023) -
ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target
por: Kimura, Kenji, et al.
Publicado: (2020) -
The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers
por: Kimura, Hirokazu, et al.
Publicado: (2021) -
Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells
por: Chatterjee, Sushmita, et al.
Publicado: (2023) -
G–CSF–producing left lung squamous cell carcinoma positive for ROS1 rearrangements completely resected after neoadjuvant radiation chemotherapy: A case report
por: Samejima, Hironobu, et al.
Publicado: (2022)